Skip to content

Public FDA record

Z-1542-2018: Alere iScreen Dx Urine Drug Screen Card

Recall record Z-1542-2018 for Ameditech Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1542-2018
Company in FDA record
Ameditech Inc
FDA record creation date
Apr 28, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

The kit box label incorrectly identifies Phencyclidine (PCP), where it should list Tricyclic Antidepressants (TCA) as one of the 10 drug analytes included in the kit box.

Source facts

Action
Customers were notified on about 12/15/2017. Instructions included to become aware of the recall so as to relay the information to customers with questions.
Initiated
2017-12-15
Root cause
Labeling Change Control
Terminated
2019-02-11
Distribution
Distributed domestically to AZ, FL, IL, ND, NV, PA, TN, TX, VA.
Recall number
Z-1542-2018
Recall status
Terminated
CDRH record ID
162621
FDA record created
2018-04-28
Recall event number
79549

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗